Extrapulmonary Soft-Tissue Fibrosis Resulting From Hypofractionated Stereotactic Body Radiotherapy for Pulmonary Nodular Lesions

International Journal of Radiation Oncology Biology Physics

Volumn 74, Issue 2, 2009, Pages 349-354

  Kawase, Takatsugu ^a   Takeda, Atsuya ^b,c   Kunieda, Etsuo ^a,c   Kokubo, Masaki ^d   Kamikubo, Yoshifumi ^e   Ishibashi, Ryouchi ^e   Nagaoka, Tomoaki ^f   Shigematsu, Naoyuki ^a   Kubo, Atsushi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OFUNA CHUO HOSPITAL   (Japan)

^c TOKYO METROPOLITAN HIROO HOSPITAL   (Japan)

^d INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^e Federation of National Public Service Personnel Mutual Aid Associations   (Japan)

^f NATIONAL INSTITUTE OF INFORMATION AND COMMUNICATIONS TECHNOLOGY   (Japan)

Author keywords

Fibrosis; Lung cancer; Radiation toxicity; Stereotactic body radiotherapy

Indexed keywords

18-F-FLUORODEOXYGLUCOSE; CHEST PAINS; COMPUTED TOMOGRAPHY SCANS; DOSE PRESCRIPTIONS; DOSE-VOLUME HISTOGRAMS; FIBROSIS; ISOCENTER; LUNG CANCER; LUNG TUMORS; LYMPHEDEMA; MALIGNANT CELLS; NEEDLE BIOPSIES; NODULAR LESIONS; RADIATION TOXICITY; SHAPE MODIFICATIONS; SOFT TISSUES; STANDARDIZED UPTAKE VALUES; STEREOTACTIC BODY RADIOTHERAPY; TREATMENT PLANNING; UP TIME;

BIOLOGICAL ORGANS; BIOPSY; CHEMICAL MODIFICATION; COMPUTERIZED TOMOGRAPHY; MEDICAL IMAGING; RADIOTHERAPY; TOXICITY;

POSITRON EMISSION TOMOGRAPHY;

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARM EDEMA; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; FEMALE; FIBROSIS; FOLLOW UP; FOREARM; HISTOGRAM; HUMAN; IMAGE ANALYSIS; INCIDENCE; LUNG CANCER; LUNG NODULE; LYMPHEDEMA; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; NEUROPATHY; PARESTHESIA; PERCUTANEOUS BIOPSY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; SOFT TISSUE TUMOR; STEREOTACTIC BODY RADIATION THERAPY; SWELLING; THORAX PAIN; TREATMENT PLANNING;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DOSE FRACTIONATION; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIATION INJURIES; RADIOSURGERY; RELATIVE BIOLOGICAL EFFECTIVENESS; THORACIC WALL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 65449164903     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.08.072     Document Type: Article

References (36)

1. Uematsu M., Shioda A., Tahara K., et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: A preliminary experience. Cancer 82 (1998) 1062-1070
2. Wulf J., Hadinger U., Oppitz U., et al. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 177 (2001) 645-655
3. Uematsu M., Shioda A., Suda A., et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small-cell lung cancer: A 5-year experience. Int J Radiat Oncol Biol Phys 51 (2001) 666-670
4. Timmerman R., Papiez L., McGarry R., et al. Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 124 (2003) 1946-1955
5. Onishi H., Araki T., Shirato H., et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multi-institutional study. Cancer 101 (2004) 1623-1631
6. Takeda A., Sanuki N., Kunieda E., et al. Stereotactic body radiotherapy for primary lung cancer at a dose of 50 Gy Total in five fractions to the periphery of the planning target volume calculated using a superposition algorithm. Int J Radiat Oncol Biol Phys 73 (2009) 442-448
7. Onimaru R., Shirato H., Shimizu S., et al. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys 56 (2003) 126-135
8. Uno T., Aruga T., Isobe K., et al. Radiation bronchitis in lung cancer patient treated with stereotactic radiation therapy. Radiat Med 21 (2003) 228-231
9. Bradley J., Graham M.V., Winter K., et al. Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 318-328
10. Zimmermann F.B., Geinitz H., Schill S., et al. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Lung Cancer 48 (2005) 107-114
11. Nyman J., Johansson K.A., and Hulten U. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer-Mature results for medically inoperable patients. Lung Cancer 51 (2006) 97-103
12. Timmerman R., McGarry R., Yiannoutsos C., et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24 (2006) 4833-4839
13. Takeda A., Enomoto T., Sanuki N., et al. Acute exacerbation of subclinical idiopathic pulmonary fibrosis triggered by hypofractionated stereotactic body radiotherapy in a patient with primary lung cancer and slightly focal honeycombing. Radiat Med 26 (2009) 504-507
14. Gong Q.Y., Zheng G.L., and Zhu H.Y. MRI differentiation of recurrent nasopharyngeal carcinoma from postradiation fibrosis. Comput Med Imaging Graph 15 (1991) 423-429
15. Becker M., Schroth G., Zbaren P., et al. Long-term changes induced by high-dose irradiation of the head and neck region: Imaging findings. Radiographics 17 (1997) 5-26
16. O'Sullivan B., and Levin W. Late radiation-related fibrosis: pathogenesis, manifestations, and current management. Semin Radiat Oncol 13 (2003) 274-289
17. Davis A.M., O'Sullivan B., Turcotte R., et al. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol 75 (2005) 48-53
18. Takeda A., Kunieda E., Shigematsu N., et al. Small lung tumors: Long-scan-time CT for planning of hypofractionated stereotactic radiation therapy-Initial findings. Radiology 237 (2005) 295-300
19. Fowler J.F., Tome W.A., Fenwick J.D., et al. A challenge to traditional radiation oncology. Int J Radiat Oncol Biol Phys 60 (2004) 1241-1256
20. Johansson S., Svensson H., and Denekamp J. Dose response and latency for radiation-induced fibrosis, edema, and neuropathy in breast cancer patients. Int J Radiat Oncol Biol Phys 52 (2002) 1207-1219
21. Olsen N.K., Pfeiffer P., Mondrup K., et al. Radiation-induced brachial plexus neuropathy in breast cancer patients. Acta Oncol 29 (1990) 885-890
22. Schierle C., and Winograd J.M. Radiation-induced brachial plexopathy: Review-Complication without a cure. J Reconstr Microsurg 20 (2004) 149-152
23. Jaeckle K.A. Neurological manifestations of neoplastic and radiation-induced plexopathies. Semin Neurol 24 (2004) 385-393
24. Johansson S. Radiation induced brachial plexopathies. Acta Oncol 45 (2006) 253-257
25. Kinsella T.J., DeLuca A.M., Barnes M., et al. Threshold dose for peripheral neuropathy following intraoperative radiotherapy (IORT) in a large animal model. Int J Radiat Oncol Biol Phys 20 (1991) 697-701
26. Vujaskovic Z., Powers B.E., Paardekoper G., et al. Effects of intraoperative irradiation (IORT) and intraoperative hyperthermia (IOHT) on canine sciatic nerve: Histopathological and morphometric studies. Int J Radiat Oncol Biol Phys 43 (1999) 1103-1109
27. Meek A.G. Breast radiotherapy and lymphedema. Cancer 83 (1998) 2788-2797
28. Brennan M.J., and Miller L.T. Overview of treatment options and review of the current role and use of compression garments, intermittent pumps, and exercise in the management of lymphedema. Cancer 83 (1998) 2821-2827
29. Filippetti M., Santoro E., Graziano F., et al. Modern therapeutic approaches to postmastectomy brachial lymphedema. Microsurgery 15 (1994) 604-610
30. Campisi C., and Boccardo F. Frontiers in lymphatic microsurgery. Microsurgery 18 (1998) 462-471
31. Gillette E.L., Mahler P.A., Powers B.E., et al. Late radiation injury to muscle and peripheral nerves. Int J Radiat Oncol Biol Phys 31 (1995) 1309-1318
32. Blomlie V., Rofstad E.K., Tvera K., et al. Noncritical soft tissues of the female pelvis: Serial MR imaging before, during, and after radiation therapy. Radiology 199 (1996) 461-468
33. Takeda A., Kunieda E., Takeda T., et al. Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumor recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 70 (2008) 1057-1065
34. Patz Jr. E.F., Lowe V.J., Hoffman J.M., et al. Persistent or recurrent bronchogenic carcinoma: Detection with PET and 2-[F-18]-2-deoxy-d-glucose. Radiology 191 (1994) 379-382
35. Inoue T., Kim E.E., Komaki R., et al. Detecting recurrent or residual lung cancer with FDG-PET. J Nucl Med 36 (1995) 788-793
36. Hoopes D.J., Tann M., Fletcher J.W., et al. FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer. Lung Cancer 56 (2007) 229-234